Poland: R&D activities; individual depreciation rate for certain non-residential premises
Summaries of recent decisions of the Supreme Administrative Court
Summaries of recent decisions of the Supreme Administrative Court
The KPMG member firm in Poland prepared a report that includes summaries of the following recent decisions of the Supreme Administrative Court.
- The court on 28 November 2023 held that the activities of a taxpayer engaged primarily in sales of specialized equipment for chromatography, spectroscopy, optics, mass spectrometry, bioanalyzer systems, and advance surface analysers could be treated as research and development (R&D).
- The court on 23 November 2023 held (case file II FSK 247/22) individual depreciation rates under Article 22j(1) of the individual (personal) income tax law may apply to non-residential premises separated out of a hotel property, registered in the register of tangible and intangible assets, and used in business activity.
Read a December 2023 report prepared by the KPMG member firm in Poland
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.